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A B S T R A C T
The aim of this study was to investigate both the efficacy and safety of sedation with
propofol during urgent therapeutic gastroscopy in patients with upper gastrointestinal
bleeding. This prospective study included a total of 110 patients. Propofol was adminis-
tered intravenously at the starting dose of 1 mg/kg body weight and was followed by re-
peated doses. Oxygen saturation and heart rate were monitored by pulse oxymetry. The
mean dose of propofol administered was 161  49 mg. Urgent upper GI endoscopy under
propofol sedation was successful in 98% of cases. Endoscopists rated the sedation as
good in 83.6%, satisfactory in 14.5%, and poor in 1.8% of patients. Potentially harmful
drop in oxygen saturation below 85% was observed in 5.5% of patients, whereas a tem-
porary drop in heart rate below 50 beats/min was observed in 11.8%, not requiring any
intervention. Almost 93% of patients could not remember the beginning or the end of the
intervention. This data demonstrates that sedation with propofol is suitable for use in
patients with upper gastrointestinal bleeding undergoing urgent endoscopy.
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Introduction
Over the past two decades, endoscopy
has evolved from being a diagnostic tool
to being the initial therapeutic interven-
tion of choice in acute upper gastrointes-
tinal (GI) bleeding. Remarkable advances
have been made in the therapeutic endos-
copy of bleeding upper GI lesions, in-
cluding various hemostatic techniques
such as hemoclips, loops and ligations
and various forms of thermal or injec-
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tional methods1,2. Such therapeutic endo-
scopic procedures are frequently prolon-
ged, and require optimal patient co-ope-
ration.
Propofol is a relatively new intrave-
nous sedative hypnotic that is used for
the induction and maintenance of con-
scious sedation in GI endoscopy. Based on
its use in gastroscopy3,4, colonoscopy5,6,
and ERCP7,8, propofol has been proved to
be a suitable sedative in gastroentero-
logical endoscopy. Furthermore, in recen-
tly published clinical trials intravenous
sedation with propofol was found to be
more effective than sedation with mida-
zolam9–11. However, to our knowledge,
there is no prospective study that has as-
sessed the safety and efficacy of propofol
for conscious sedation during urgent en-
doscopic procedures in patients with up-
per GI bleedings. Therefore, the aim of
this prospective study was to investigate
the efficacy and safety profile of sedation
with propofol during urgent therapeutic
gastroscopy in patients with upper GI
bleeding that included many elderly indi-
viduals with multiple comorbidity prob-
lems, typical of the patient profile cur-
rently seen in major hospitals worldwide.
Patients and Methods
Between January 2001 and December
2001, patients admitted for upper GI
bleeding in the Endoscopy Unit of the Di-
vision of Gastroenterology at the Univer-
sity Hospital »Sestre milosrdnice«, Zag-
reb, were considered for the study. Upper
GI bleeding was suspected only if medical
staff members witnessed hematemesis
and/or melena, observed bloody nasogas-
tric aspirate or detected black, tarry ma-
terial on digital rectal examination. Pa-
tients were included in the study if the
emergency upper GI endoscopy has been
done under sedation with propofol alone.
Use of additional sedative or analgesic
drugs was not allowed. Exclusion criteria
included pregnancy, patients under the
age of 18 or older than 80 years, those
who could not give informed consent, pa-
tients with severe congestive heart fail-
ure, torrential hemorrhage with persis-
tent shock, unconsciousness or known
hypersensitivity to propofol. Patients on
regular dialysis, patients with heart rate
lower than 40 beats per minute and those
with tachyarrhythmias, or baseline oxy-
gen saturation lower than 85% were also
excluded from the study.
This prospective and nonrandomized
study included a total of 110 patients who
underwent urgent upper GI endoscopy.
Written consent was obtained from each
patient, and the local ethics committee
had approved the study.
Endoscopic setting
All urgent upper GI endoscopies were
done with Olympus EVIS 140 video endo-
scopes by skilled endoscopists, each with
at least five years experience in the treat-
ment of patients with upper GI bleeding.
Urgent endoscopy was always performed
within six hours of hospital admission.
Following endoscopy, the endoscopist
filled out a questionnaire rating the ade-
quacy of sedation as: (1) good (complica-
tion-free intervention with adequately se-
dated patient), (2) satisfactory (restless
patient; the procedure was successfully
completed), and (3) poor (intervention
had to be aborted due to the insufficient
sedation or severe side effects). Separate
questions were related to the presence of
any adverse effects and possible interven-
tions. The length of the endoscopic proce-
dure has also been recorded.
Anesthetic procedure and monitoring
of patients
Endoscopic procedures were carried
out without tracheal intubation. Sedation
was performed exclusively with propofol
administered by a skilled nurse who was
present throughout the procedure. Propo-
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fol (Propofol® 1%, Fresenius Kabi, South
Africa; Diprivan®, Astra Zeneca, Great
Britain) was administered intravenously
at the starting dose of 1 mg/kg body weight
and was followed by repeated doses of 20
mg intravenously at two-minutes inter-
vals until complete sedation had been
achieved (maximal sedation level without
response). The maximal initial dose of
propofol was set subjectively at 200 mg. If
the maximal dose did not lead to suffi-
cient sedation or if severe side effects oc-
curred, intervention has been aborted.
Sedation was maintained by administer-
ing a bolus of 10 to 20 mg of propofol in-
travenously every time the patient’s re-
sistance was noted, making the endosco-
pic procedure difficult to perform.
All patients received supplemental ox-
ygen (10 L/min) via a nasal cannula.
Oxygen saturation and heart rate we-
re monitored by pulse oxymetry (Spenser
Otis 3000, USA). Blood pressure was mea-
sured at 5-minute intervals during the
first 15 minutes of the intervention, and
then every 10 to 15 minutes afterwards.
Hypoxia was defined as oxygen satu-
ration below 85% over at least 30 sec-
onds. Adverse reactions such as injection
pain, coughing reflex, headache and pha-
ses of apnea were also recorded.
The recovery time after completion of
the upper GI endoscopy was measured
using the Stewart score, which assessed
respiration, consciousness and motor co-
ordination12.
All patients were carefully monitored
for a minimum of one hour prior to the
admittance to the Intensive Care Unit
where any delayed effects of sedation were
also documented.
Statistical analysis
All values were reported as means 
standard deviations or medians where
appropriate. Statistical analysis was per-
formed using the Mann-Whitney U-test
where appropriate (Statistica for Win-
dows, Statsoft Inc., USA). Values of p<
0.05 were considered significant.
Results
A total of 110 patients who underwent
urgent upper GI endoscopy received pro-
pofol. There were 49 women and 61 men,
mean age 5513 years (range 22 to 78
years). Some patients' characteristics with
respect to potential impact on degree and
quality of sedation were presented in Ta-
ble 1.
During urgent endoscopy the cause of
upper gastrointestinal bleeding was iden-
tified in 109 patients (99%), (Table 2).
Interventional hemostatic procedures du-
ring urgent upper GI endoscopy have
been used in 79 patients (71.8%). Median
of duration of urgent upper GI endoscopy
under propofol sedation was 39 minutes
(ranging 10 to 90 minutes).
The mean dose of propofol adminis-
tered was 16149 mg (with a range of 80
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TABLE 1
CHARACTERISTICS OF 110 INVESTIGATED
PATIENTS (49 FEMALES, 61 MALES), AGE
RANGED FROM 22 TO 78 YEARS (5513)
N (%)
Alcohol abuse 63 (57.3%)
Smokers 70 (63.6%)
Regular use of sedative
or psychotropic drugs 19 (17.3%)
Shock 8 (7.3%)
Hemoglobin concentrations (g/L) 27 (24.5%)
Comorbidity
Cardiovascular disease 48 (43.6%)
Liver cirrhosis 40 (36.4%)
Respiratory disease 12 (10.9%)
Diabetes mellitus 10 (9.1%)
Renal failure 9 (8.2%)
Mortality 3 (2.7%)
to 390 mg). The individual propofol dose
used was mainly dependent on body
weight and the duration of the procedure.
There was also a significant difference
between the dose of propofol used and the
presence of hepatic failure (determined as
a bilirubin concentration above 40 mmol/L
with at least twofold increase in AST and
ALT concentrations), (106  31 mg vs.
176  44 mg, p<0.001), (Table 3).
Sedation efficacy
Urgent upper GI endoscopy under pro-
pofol sedation was successful in 98% of
cases (108 out of 110 patients). Endo-
scopists rated the sedation as good in 92
patients (83.6%), satisfactory in 16 pa-
tients (14.5%), and poor in two (1.8%),
(Figure 1). Te two patients in whom ur-
gent endoscopy under propofol sedation
was not successful had advanced alco-
holic liver cirrhosis and both required
therapeutic procedures relating to esoph-
ageal variceal hemorrhage and a bleeding
Dieulafoy stomach lesion, respectively (in
patient with bleeding esophageal varices
endoscopy had to be aborted due to insuf-
ficient sedation, whereas in patient with
a bleeding Dieulafoy's lesion severe side
effect occurred: an epileptic seizure with
short apnea and a prolonged decrease in
oxygen saturation – completely reversible
after withdrawal of the endoscope and
without consequence during the follow-
up period). In these patients, endoscopy
had been successfully performed immedi-
ately after the unsuccessful sedation with
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TABLE 2
ENDOSCOPIC DIAGNOSES AND HEMOSTATIC
PROCEDURES (N=110)
Endoscopic diagnosis N (%)








Bleeding Mallory-Weiss tears 8 (7.3)
Hemoclip therapy 3
Without therapy 5
Bleeding gastric erosions 7 (6.4)




Argon plasma coagulator 2
Without therapy 3
Bleeding gastric carcinoma 4 (3.6)
Argon plasma coagulator 2
Without therapy 2
Bleeding watermelon stomach 2 (1.8)
Argon plasma coagulator 2
Gastric variceal hemorrhage 2 (1.8)
Variceal obliteration 2
Bleeding angiectasiae 2 (1.8)
Ligation 1
Hemoclip therapy 1
Bleeding Dieulafoy lesion 2 (1.8)




DOSES OF PROPOFOL IN PATIENTS WITH AND WITHOUT HEPATIC FAILURE (N=110)
Number of patients









propofol, but this time without any form
of sedation.
Vital signs and adverse effects
The mean decline in oxygen satura-
tion (initial oxygen saturation versus
lowest oxygen saturation during the en-
doscopy) was 53%. Potentially harmful
drop in oxygen saturation below 85% was
observed in six patients (5.5%). Oxygen
desaturation was short-lasting in five pa-
tients (4.5%). Endoscopic suction in all
those patients resulted in a fast increase
in oxygen saturation. In only one patient,
an epileptic seizure and short-time apnea
developed. After withdrawal of the endo-
scope, the patient started to breath spon-
taneously and the epileptic attack stop-
ped before any additional medication was
given and assisted ventilation was ap-
plied. She did not develop any late se-
quels from the event.
A temporary drop in heart rate below
50 beats/min was observed in 13 patients
(11.8%), but did not require any interven-
tion. In only one patient undergoing pro-
pofol sedation, tachyarrhythmia (with a
median heart rate of 200 beats/min) oc-
curred, without any signs of hypotension
or hypoxia. Ten minutes after the thera-
peutic procedure had been successfully
performed and endoscope has been with-
drawn, tachyarrhytmia stopped sponta-
neously. No residual effects had been ob-
served during the follow-up period.
Mean decrease in the mean arterial
blood pressure (initial blood pressure ver-
sus minimal blood pressure value during
the endoscopy) was 129 mmHg.
In only one patient with significant
hypotension and shock, hypotension was
prolonged (lasting more than one hour af-
ter the intervention).
Pain at the injection site was noted in
only one patient.
Transient hiccups were present in a
majority of patients (59 out of 110 pa-
tients, 53.6%), whereas cough reflex was
seen in only 6 (5.5%) patients.
Patient's recovery
All patients who underwent urgent
upper GI endoscopy under intravenous
propofol sedation had achieved the total
Steward score by 30 minutes. Almost
93% of patients (102 out of 110 patients)
could not remember the beginning or the
end of the intervention.
Discussion
The need for proper sedation of pa-
tients with upper gastrointestinal bleed-
ing during urgent upper gastrointestinal
endoscopy is evident particularly if tech-
nically demanding endoscopic procedures
have to be performed. Interventional the-
rapeutic procedures during upper gastro-
intestinal bleeding sometimes last more
than one hour, are potentially unpleasant
to the patient, and therefore are not ac-
ceptable without sedation.
Propofol, 2.6 diisopropylphenol is an
ultra-short acting sedative hypnotic agent
that has received much attention, for use
during gastrointestinal endoscopy13. Pro-
pofol may be ideal for sedation of bleeding
patients during urgent upper gastroin-
testinal therapeutic procedures because
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Fig. 1. Sedation quality as rated by the
endoscopist.
of its rapid onset of sedative action, easy
titrability, and short duration of effect14.
The results of this prospective and con-
trolled study clearly demonstrate that
propofol provides very effective sedation
during urgent upper gastrointestinal en-
doscopy performed in patients with upper
gastrointestinal bleeding. Endoscopists
rated the sedation as good or satisfactory
in more than 98 percent of cases. It is
very important to emphasize that inter-
ventional hemostatic procedures have been
done in more than 83 percent of patients,
and that median of duration of urgent en-
doscopy under propofol sedation was 39
minutes.
Adverse reactions of propofol are rare
and have only brief duration, as a result
of its short half-life. Respiratory depres-
sion and cardiovascular adverse effects
such as hypotension or bradycardia have
been associated with propofol use15. How-
ever, in majority of clinical studies no se-
rious complications were observed upon
propofol sedation although these studies
were carried out mostly on patients with
relatively good general health3–11.
Despite the fact that in our study
there were many elderly individuals with
multiple, and in many cases significant
comorbidity, serious complications were
seen in a very small percentage of pa-
tients suggesting that the propofol safety
profile in elderly seems to be comparable
to the one in young adults. According to
our observations, significant problems re-
garding both the efficacy and safety of
propofol can be associated with propofol
administration in patients with advanced
liver failure. There is a strong correlation
between the individual propofol dose
used and the presence of significant he-
patic failure. It seems possible that the
high overall dosage of propofol is directly
related to the adverse effects since most
of our patients in whom we observed car-
diorespiratory adverse effects of propofol
were patients with liver failure.
As has been noted in previous studies,
the predominant cardiovascular effect of
propofol is a reduction in the systemic
vascular resistance, which may induce
hypotension16. Despite the fact that the
decrease in mean arterial pressure has
been also observed among patients in this
study, it must be emphasized that only
one patient with significant hypotension
and shock had prolonged hypotension af-
ter the sedation with propofol, but with-
out any clinically relevant consequences.
In conclusion, this data demonstrates
that sedation with propofol is suitable for
use in patients with upper gastrointesti-
nal bleeding undergoing urgent endos-
copy. Although the complication rate is
very low and complications are of short
duration close monitoring of the sedated
patient is mandatory.
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DJELOTVORNOST I SIGURNOST SEDACIJE PROPOFOLOM TIJEKOM
URGENTNE ENDOSKOPIJE GORNJEG DIJELA PROBAVNOG SUSTAVA:
PROSPEKTIVNA STUDIJA
S A @ E T A K
Cilj ove prospektivne studije bio je istra`iti sigurnost i djelotvornost propofola u
sedaciji tijekom endoskopskih zahvata u bolesnika s krvarenjem iz gornjeg dijela pro-
bavnog sustava. U studiju je bilo uklju~eno 110 bolesnika u kojih je na~injena urgentna
endoskopija. Propofol je primijenjen intravenski u po~etnoj dozi od 1 mg/kg tjelesne
te`ine, uz dodavanje lijeka do postizanja potpune sedacije. Saturacija kisikom i sr~ana
frekvencija pra}eni su putem pulsnog oksimetra. Prosje~na doza primijenjenog pro-
pofola je bila 161 ± 49 mg. Hitna endoskopija gornjeg dijela probavnog sustava bila je
uspje{na u 98% slu~ajeva. Endoskopi~ari su ocijenili sedaciju kao dobru u 83,6%, za-
dovoljavaju}u u 14,4% te lo{u u 1,8% bolesnika. Potencijalno opasan pad u saturaciji
kisikom ispod 85% zabilje`en je u 5,5% bolesnika, dok je kratkotrajna bradikardija
(<50 otkucaja/min) zamije}ena u 11,8% bolesnika, ali nije zahtijevala nikakav terapij-
ski pristup. Gotovo je 93% bolesnika imalo amneziju za sam po~etak i kraj endoskop-
skog zahvata. Ovi podaci pokazuju da je sedacija propofolom pogodna za sedaciju bo-
lesnika s krvarenjem iz gornjih dijelova probavnog sustava u kojih je potrebno u~initi
hitnu endoskopiju.
